Double-blind Placebo-controlled 2-part Study Assessing the Safety, Tolerability and PK of AZD1386 in Healthy Volunteers

NCT00945178 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped The study was terminated due to results in another study (NCT00878501).

Conditions

Healthy Volunteers

Interventions

DRUG: AZD1386
DRUG: Placebo for AZD1386
DRUG: Naproxen
DRUG: Placebo for Naproxen

Sponsor

AstraZeneca